Datamatics Global Services has reported its unaudited financial results for the quarter and half year ended September 30, 2025, showing strong performance across key metrics.

Financial Highlights

The company's consolidated net profit for the quarter ended September 30, 2025, rose to ₹63.24 crore from ₹42.36 crore in the corresponding quarter of the previous year, marking a substantial 49.3% increase. This growth was supported by a 20.5% year-over-year rise in revenue, which reached ₹490.23 crore compared to ₹406.75 crore in the same period last year.

Operational Performance

Datamatics witnessed a remarkable improvement in its operational efficiency, with EBITDA surging to ₹88.80 crore from ₹48.76 crore in the year-ago quarter. The EBITDA margin expanded significantly to 18.12% from 11.99%, reflecting enhanced profitability and operational excellence.

Segment-wise Performance

The company's performance was driven by growth across its three main business segments:

1. Digital Operations: Emerged as the largest revenue contributor with ₹272.48 crore.
2. Digital Technologies: Generated revenue of ₹153.13 crore.
3. Digital Experiences: Contributed ₹64.62 crore to the total revenue.

The total segment revenue for the quarter was ₹490.23 crore.

Corporate Developments

• The company appointed Mr. Mahesh Zurale as Additional Director to serve as Independent Director for a 2-year term starting October 30, 2025, subject to shareholder approval.
• The board approved a revised policy on Code of Conduct for regulating, monitoring and reporting of trading by insiders and code of practice for fair disclosure.

Investments and Subsidiaries

Datamatics has investments of ₹11.05 crore in preference shares and ₹36.14 crore in perpetual debentures in a step-down subsidiary that has a negative net worth of ₹30.78 crore. Management expects this RPA business subsidiary to turn around given its growth stage and profit generation potential.

Future Outlook

While specific forward-looking statements were not provided, the company's consistent performance and growth across segments indicate a positive outlook. The management's expectation for the RPA business subsidiary to turn around suggests confidence in future growth prospects.

Datamatics Global Services continues to demonstrate its resilience and adaptability in the IT services market, as reflected in its quarterly performance and strategic initiatives.

Datamatics Global Services Limited , a leader in digital technologies, has announced a significant partnership with Well Pharmacy, the UK's largest independent pharmacy chain. This collaboration aims to modernize medication record-keeping for patients in care homes, leveraging Datamatics' AI-powered automation platforms.

Partnership Details

Well Pharmacy, operating over 650 pharmacies across the UK with an annual revenue of approximately £800 million, has signed a long-term contract with Datamatics. The partnership will focus on automating the Medication Administration Record (MAR) process, utilizing Datamatics' intelligent automation products:

• TruCap+: For Intelligent Document Processing (IDP)
• TruBot: For Robotic Process Automation (RPA)

Automation Benefits

The implementation of these AI-powered platforms is expected to bring several advantages:

Scope and Impact

The automation initiative aims to create reliable Monitored Dosage System (MDS) records while enhancing patient safety. Well Pharmacy plans to scale this solution to support over 70,000 patients in care homes, significantly impacting the UK's healthcare landscape.

Strategic Importance

This partnership reinforces Datamatics' position in the global healthcare sector. Notably, Datamatics' Intelligent Automation platform is already empaneled by NHS Shared Business Services in the UK, highlighting its growing influence in the healthcare industry.

Andrew Caplan, Chief Retail Officer from Well Pharmacy, emphasized the critical nature of accuracy in the medical industry and how this partnership provides a flexible, easy-to-use solution ensuring precision while simplifying complex processes.

Mitul Mehta, Chief Marketing Officer at Datamatics, expressed excitement about the partnership, stating, "With our experience in the Healthcare industry, we are confident to deliver the desired benefits of automation including accuracy, efficiency and process compliance."

This collaboration between Datamatics and Well Pharmacy represents a significant step forward in the digital transformation of healthcare services, promising to enhance patient care through innovative technology solutions.